UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Roche Korea’s lung cancer drug increases cost-effectiveness
Roche Korea said Thursday Alecensa (ingredient: alectinib) would get cheape...
by Marian Chu
|
2017-10-12 14:59
라인
Rethink obesity, says Novo Nordisk Korea
Obesity should no longer be seen as the result of individuals’ habits but r...
by Marian Chu
|
2017-10-12 11:20
라인
AstraZeneca’s ovarian cancer drug more affordable
AstraZeneca Korea said Friday its ovarian cancer drug Lynparza began to rec...
by Marian Chu
|
2017-10-11 18:14
라인
Boryung to sell antihypertensive drugs in SE Asia
South Korea’s Boryung Pharmaceutical said it would sell its antihypertensiv...
by Lee Hye-seon
|
2017-10-11 16:02
라인
Daewoong to sell Novartis’ osteoporosis drug
Daewoong pharmaceutical said Wednesday it acquired marketing and commercial...
by Marian Chu
|
2017-10-11 11:39
라인
Green Cross units sign MOU with Sudan Central Lab
Green Cross MS and Green Cross Laboratories have signed a memorandum of und...
by Lee Han-soo
|
2017-10-10 15:53
라인
SK Chemicals ‘Skyzoster’ wins sales approval
SK Chemicals received the sales approval for Skyzoster, a shingles vaccine,...
by Lee Han-soo
|
2017-10-10 12:16
라인
Immunotherapy developers engage in fierce competition to expand indications
Bristol-Myers Squibb and Merck & Co are conducting several clinical trials ...
by Marian Chu
|
2017-10-05 06:00
라인
Dongkook Pharm, Madagascar government to develop natural medicines
Dongkook Pharmaceuticals said Friday that it has signed an agreement with t...
by Lee Han-soo
|
2017-09-29 17:39
라인
AbbVie’s hepatitis C treatment approved in Japan
AbbVie said Thursday that its G/P (glecaprevir/pibrentasivr) treatment, sho...
by Marian Chu
|
2017-09-29 12:03
라인
Korea lags behind osteoporosis prevention and treatment
Osteoporosis prevention and treatment has been rather overlooked in Korea, ...
by Marian Chu
|
2017-09-29 10:21
라인
World’s best-selling drug Humira gains insurance coverage in Korea
AbbVie Korea said Thursday its blockbuster biologic Humira gained nationwid...
by Marian Chu
|
2017-09-28 19:02
라인
Amgen Korea’s osteoporosis treatment gets insurance coverage
Amgen Korea said Thursday its “first and only” biologic treatment for osteo...
by Marian Chu
|
2017-09-28 19:02
라인
Korean drugmakers’ smart factories at ‘base level’
An increasing number of Korean pharmaceutical firms have built smart factor...
by Nam Doo-hyun
|
2017-09-28 16:00
라인
Drugmakers need to differentiate big data from ‘large data’
It is necessary for Korean pharmaceutical companies to distinguish big data...
by Nam Doo-hyun
|
2017-09-27 17:44
라인
Exelixis’ kidney cancer drug gains approval in Korea
The Ministry of Food and Drug Safety approved Friday Exelixis’ kidney drug ...
by Marian Chu
|
2017-09-27 17:44
라인
Korean combos, incrementally modified drugs to get insurance benefits
Korean combination drugs for hypertension, diabetes, and hyperlipidemia, an...
by Lee Hye-seon
|
2017-09-27 11:29
라인
Ilyang presents leukemia treatment’s clinical results
Ilyang Pharmaceuticals Tuesday released its phase 3 clinical trial result o...
by Lee Han-soo
|
2017-09-26 17:31
라인
Ministry changes dosage recommendation for Bayer’s blood-thinning drug
The Ministry of Food and Drug Safety said Friday it has revised dosage reco...
by Marian Chu
|
2017-09-26 16:24
라인
‘Keytruda will beat Opdivo in US because of biomarker’
"Opdivo had gone ahead of Keytruda in America until last year, but Keytruda...
by Nam Doo-hyun
|
2017-09-26 15:57
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top